menu
    • menu

    Company profile for RevOpsis Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RevOpsis Therapeutics is an innovative biopharmaceutical firm spearheading a revolutionary approach to multispecific antibody discovery and advancement, aiming to unlock groundbreaking therapies for intricate diseases. Our methodology is straightforward: leveraging our exclusive Rev-Mod Platform, we employ a modular plug-and-play system to simplify the process of drug discovery and development. This platform boasts a repositor...
    RevOpsis Therapeutics is an innovative biopharmaceutical firm spearheading a revolutionary approach to multispecific antibody discovery and advancement, aiming to unlock groundbreaking therapies for intricate diseases. Our methodology is straightforward: leveraging our exclusive Rev-Mod Platform, we employ a modular plug-and-play system to simplify the process of drug discovery and development. This platform boasts a repository of approximately 30 billion fully human and compatible antibody components, primed for integration into functional Multi-Mod biologics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RevOpsis TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4109 Chandlerwood Suite B. Dover, Delaware, 62711, United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.revopsis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/revopsis/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Asimov and RevOpsis Partner to Advance Ophthalmic Therapeutics
    Asimov and RevOpsis Partner to Advance Ophthalmic Therapeutics

    19 Nov 2024

    // CONTRACTPHARMA

    https://www.contractpharma.com//contents/view_breaking-news/2024-11-19/asimov-and-revopsis-partner-to-advance-ophthalmic-therapeutics/?widget=listSection

    CONTRACTPHARMA
    19 Nov 2024
    Share Share
    RevOpsis Awarded $1.8M Grant To Advance Ophthalmic Therapies
    RevOpsis Awarded $1.8M Grant To Advance Ophthalmic Therapies

    15 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revopsis-therapeutics-awarded-1-8m-nei-sbir-grant-to-advance-rd-for-groundbreaking-ophthalmic-therapies-302276752.html

    PR NEWSWIRE
    15 Oct 2024
    Share Share
    RevOpsis and Kemwell partner to boost biologic development
    RevOpsis and Kemwell partner to boost biologic development

    18 Jun 2024

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/revopsis-kemwell-biologic-development/

    PHARMACEUTICAL TECHNOLOGY
    18 Jun 2024
    Share Share
    RevOpsis And Kemwell Enter Partnership For Novel Biologics Development
    RevOpsis And Kemwell Enter Partnership For Novel Biologics Development

    17 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revopsis-and-kemwell-biopharma-enter-into-strategic-manufacturing-partnership-to-expedite-development-of-novel-multispecific-biologics-302174227.html

    PR NEWSWIRE
    17 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search